Coccidiosis: Clinical Trials

72 trials for Coccidiosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

44 completed, 11 unknown, 7 recruiting, 6 terminated. 20 Not applicable, 12 Phase 2, 10 Phase 1, 7 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable20Completed 16, Unknown 3, Terminated 1
Phase 212Completed 7, Recruiting 2, Terminated 2, Unknown 1
Phase 110Completed 9, Terminated 1
Phase 37Completed 3, Terminated 2, Not yet recruiting 1, Unknown 1
Phase 42Completed 1, Recruiting 1

Follow Coccidiosis: new trials by email Literature Review of Coccidiosis trials Research Report on Coccidiosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nitazoxanide for Treatment of Cryptosporidium in Children
Nitazoxanide, Placebo - Cryptosporidiosis
Phase 3Not yet recruitingJohns Hopkins Bloomberg School of Public Health4802026-12-302026-09-28
The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children
Echinacea Extract - Cryptosporidium Infection
Phase 2RecruitingAl-Azhar University602026-01-182026-02-05
A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants
Cryptosporidiosis
RecruitingNovartis Pharmaceuticals302026-01-092026-07-21
Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
Cryptosporidium parvum oocysts (ABO809), EDI048, Placebo - Cryptosporidiosis
Phase 2RecruitingNovartis Pharmaceuticals802025-12-082026-08-19
Role of Circulating MicroRNAs in Differentiating Psychological Disorders Among Women With Chronic Toxoplasmosis
Circulating miRNA Expression and T. gondii Serology - Toxoplasmosis
RecruitingBenha University552025-11-202026-01-16
Isolated Positive Toxoplasma Gondii PCR in Blood
Toxoplasmosis
Not yet recruitingUniversity Hospital, Clermont-Ferrand1002025-09-012025-07-11
Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital
Cerebral Toxoplasmosis
RecruitingUniversity Hospital, Strasbourg, France302025-02-022025-12-23
Blastocystis and Cryptosporidium Infection in Colorectal Cancer Patients
ELISA / PCR - Blastocystis Infection, Cryptosporidium Infection
UnknownAssiut University542024-11-012024-04-23
Cryptosporidiosis and Enteropathogens in Bangladesh
Cryptosporidiosis
Active not recruitingUniversity of Virginia1502024-10-012025-03-30
Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis
Toxoplasmosis
RecruitingAssistance Publique - Hôpitaux de Paris2002024-08-012025-01-28
Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)
Toxoplasmosis, Cerebral, Toxoplasmosis
CompletedCentre Hospitalier de Saint-Denis532024-07-012025-06-29
Toxoplasma Gondii Infection in Both Children and Adult Patients With Hematological Malignancies
toxoplasma igG - Toxoplasmosis
Not applicableUnknownSohag University502023-08-012023-07-27
Measuring the Prevalence of Toxoplasmosis and Its Socio-economic Consequences
Presence of Toxoplasma gondii IgG Antibodies - Toxoplasmosis, Rhd
UnknownUniversity of Zurich1202023-06-262023-05-18
Evaluation of the Role of Latent Toxoplasmosis in Female Patients With Active Acne Vulgaris
Free testosterone levels and toxoplasma igG - Acne Vulgaris, Toxoplasmosis
Not applicableUnknownSohag University2002023-06-012023-03-24
Pregnancy and Congenital Toxoplasmosis
Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum. - Congenital Toxoplasmosis, Retinochoroiditis
CompletedHospices Civils de Lyon762023-05-102026-01-22
Study of Efficacy and Safety of ABO809 in Healthy Participants
Cryptosporidium parvum oocysts (ABO809) - Cryptosporidium Infection, Cryptosporidiosis
Phase 1CompletedNovartis Pharmaceuticals302022-04-072024-10-02
Cryptosporidium Species in Sohag Governorate
Cryptosporidiosis
UnknownSohag University2002022-03-012024-04-17
Diagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL)
anti-Toxoplasma gondii IgG and IgM dosage, cellular test - Toxoplasmosis, Toxoplasma Infections
Not applicableCompletedCentre Hospitalier Universitaire de Nice662021-11-172024-10-15
Dexamethasone for Cerebral Toxoplasmosis
Dexamethasone, Placebo - Toxoplasmosis, Cerebral
Phase 2UnknownUniversitas Padjadjaran1382021-04-162024-07-03
Latent Toxoplasmosis in Females With Borderline Personality Disorder
Combined schema-therapy and cognitive behavioral therapy, Psychopharmaceuticals - Borderline Personality Disorder, Toxoplasmosis
WithdrawnMarie Ociskova2021-01-012024-04-02

Showing 20 of 72. Sign in to see all of them.

Narrower conditions

Cryptosporidiosis (32)  ·  HIV Infections (27)  ·  Toxoplasmosis (27)  ·  Acquired Immunodeficiency Syndrome (20)  ·  AIDS-Related Opportunistic Infections (14)  ·  Toxoplasmosis, Cerebral (13)  ·  Diarrhea (10)  ·  Encephalitis (7)  ·  Toxoplasmosis, Congenital (6)  ·  Chorioretinitis (4)  ·  Parasitic Diseases (3)  ·  Toxoplasmosis, Ocular (3)  ·  Communicable Diseases (2)  ·  Echinococcosis (2)

Broader conditions

Protozoan Infections (72)  ·  Infections (70)  ·  Parasitic Diseases (69)  ·  Animal Diseases (32)  ·  Digestive System Diseases (32)  ·  Gastrointestinal Diseases (32)  ·  Intestinal Diseases (32)  ·  Parasitic Diseases, Animal (32)  ·  Protozoan Infections, Animal (32)  ·  Immune System Diseases (30)  ·  Intestinal Diseases, Parasitic (30)  ·  Blood-Borne Infections (29)  ·  Communicable Diseases (29)  ·  Immunologic Deficiency Syndromes (29)

Interventions

Pyrimethamine (10)  ·  Leucovorin (7)  ·  nitazoxanide (6)  ·  Azithromycin (4)  ·  Spiramycin (4)  ·  Atovaquone (3)  ·  Sulfadiazine (3)  ·  Clindamycin (2)  ·  Interleukin-12 (2)  ·  Paromomycin (2)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (2)  ·  Zidovudine (2)  ·  diclazuril (2)  ·  Base Sequence (1)  ·  CD4 Lymphocyte Count (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (14)  ·  Sohag University (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  GlaxoSmithKline (3)  ·  Hospices Civils de Lyon (3)  ·  Novartis Pharmaceuticals (3)  ·  Pfizer (3)  ·  Janssen, LP (2)  ·  Rhone-Poulenc Rorer (2)  ·  Romark Laboratories L.C. (2)  ·  Al-Azhar University (1)  ·  Assiut University (1)  ·  Benha University (1)  ·  Centers for Disease Control and Prevention (1)  ·  Centre Hospitalier Universitaire Dijon (1)

Countries

United States (28)  ·  France (14)  ·  Egypt (6)  ·  Tanzania (4)  ·  Bangladesh (2)  ·  Kenya (2)  ·  Malawi (2)  ·  Australia (1)  ·  Brazil (1)  ·  Cameroon (1)  ·  Canada (1)  ·  Czechia (1)  ·  Gabon (1)  ·  India (1)  ·  Indonesia (1)

Top investigators

Luft B (3)  ·  A. Clinton White (1)  ·  Angela Loyse, MD (1)  ·  Arthur White (1)  ·  B Luft (1)  ·  BJ Luft (1)  ·  Basma Salem, MD (1)  ·  Bertrand Nunes, MD (1)  ·  Besch CL (1)  ·  Carey J (1)  ·  Chirgwin K (1)  ·  Clara Vigneron, MD (1)

Results publications

PMID 12095806, PMID 20377408, PMID 22499837, PMID 23297680, PMID 26797214, PMID 27355620, PMID 30139372, PMID 32277809, PMID 34748385, PMID 37802567, PMID 37832036, PMID 39939648, PMID 40488529, PMID 42201116

NIH funding

2009 (1), 2015 (1), 2023 (1), R01AI041735 (1), R01AI043596 (1), U01AI167788 (1)